- Home
- NXTC vs SNYR Comparison
NXTC vs SNYR Comparison
Compare NXTC & SNYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- SNYR
- Stock Information
- Founded
- NXTC 2015
- SNYR 2010
- Country
- NXTC United States
- SNYR United States
- Employees
- NXTC N/A
- SNYR N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- SNYR
- Sector
- NXTC Health Care
- SNYR
- Exchange
- NXTC Nasdaq
- SNYR NYSE
- Market Cap
- NXTC 13.9M
- SNYR 16.6M
- IPO Year
- NXTC 2019
- SNYR N/A
- Fundamental
- Price
- NXTC $0.45
- SNYR $3.10
- Analyst Decision
- NXTC Strong Buy
- SNYR Strong Buy
- Analyst Count
- NXTC 2
- SNYR 1
- Target Price
- NXTC $3.50
- SNYR $10.00
- AVG Volume (30 Days)
- NXTC 346.6K
- SNYR 102.0K
- Earning Date
- NXTC 07-31-2025
- SNYR 08-24-2025
- Dividend Yield
- NXTC N/A
- SNYR N/A
- EPS Growth
- NXTC N/A
- SNYR N/A
- EPS
- NXTC N/A
- SNYR 0.30
- Revenue
- NXTC N/A
- SNYR $33,592,914.00
- Revenue This Year
- NXTC N/A
- SNYR $37.83
- Revenue Next Year
- NXTC N/A
- SNYR $18.39
- P/E Ratio
- NXTC N/A
- SNYR $10.23
- Revenue Growth
- NXTC N/A
- SNYR N/A
- 52 Week Low
- NXTC $0.22
- SNYR $0.36
- 52 Week High
- NXTC $1.82
- SNYR $10.00
- Technical
- Relative Strength Index (RSI)
- NXTC 44.08
- SNYR N/A
- Support Level
- NXTC $0.45
- SNYR N/A
- Resistance Level
- NXTC $0.49
- SNYR N/A
- Average True Range (ATR)
- NXTC 0.06
- SNYR 0.00
- MACD
- NXTC -0.01
- SNYR 0.00
- Stochastic Oscillator
- NXTC 0.74
- SNYR 0.00
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
About SNYR SYNERGY CHC CORP
Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.